DEA Form 161

DEA Form 161 (‘Application for Permit to Export Controlled Substances’) is the export-permit application administered by the Drug Enforcement Administration’s Diversion Control Division under 21 CFR Part 1312, with its statutory basis in the export provisions of the Controlled Substances Act (21 U.S.C. Chapter 13, Subchapter I, Part C). It is filed before a Schedule I-V controlled substance — most often a research chemical, an active pharmaceutical ingredient, or a reference standard — leaves the United States, and the application ties to one proposed shipment: a specific substance and DEA schedule, quantity, destination country, and named foreign consignee.

The form matters to research administration specifically because of a distinction that trips people up: filing Form 161 requires the applicant to already hold a DEA registration whose authorized business activity includes exporting. A plain ‘Researcher’ registration — the registration category most university and institutional labs hold to legally possess and use controlled substances in their own research — authorizes research use within the US. It does not, on its own, authorize export. DEA registrations are activity-specific under 21 CFR 1301.13‘s registration-category scheme: a registrant is authorized only for the business activities and drug schedules actually listed on its Certificate of Registration. Exporting is its own listed activity, distinct from research, manufacturing, distribution, or analytical testing.

Who can actually file it

In practice, this means:

• Registered exporters — entities holding a DEA registration that includes ‘Exporter’ as an authorized activity — are the clearest case. This is typically a specialty pharmaceutical company, a reference-standard supplier, or a contract manufacturer set up specifically to ship controlled substances internationally.
• Registered analytical labs can, in the circumstances their registration and DEA guidance permit, be positioned to handle small-quantity cross-border transfers tied to testing and reference-standard work — but this runs through their own registration’s authorized activity, not through a research registration.
• Plain researcher registrants generally cannot use Form 161 on their own registration. A university lab that wants to send a Schedule I or II research compound to an overseas collaborator cannot simply file the form itself. It needs either its own registration amended/expanded to include export authority, or — far more commonly in practice — to route the shipment through an institution or commercial partner that already holds a registered-exporter registration.

For a research administrator, the practical implication is to treat any proposal to physically ship a controlled substance to a foreign collaborator as a compliance flag the moment it’s raised, not something a lab can self-serve through its existing research registration. This is a narrower, DEA-specific analogue to the broader deemed-export and technology-transfer questions covered in CASRAI’s export-controlled research and ITAR and EAR entries — those regimes (EAR, ITAR) govern dual-use technology and defense articles under the Department of Commerce and Department of State, and are legally separate from DEA’s Controlled Substances Act export-permit regime, though a single shipment can occasionally implicate both frameworks at once.

How it relates to the other DEA import/export forms

Form 161 is one of a small family of related DEA import/export forms, and mixing them up is a common error:

• DEA Form 357 — the mirror-image application, used to import a controlled substance into the United States, rather than export one out.
• DEA Form 236 — the import/export declaration filed at the time of an actual shipment, documenting the specific transaction under an already-approved permit. Form 161 authorizes the export in principle; Form 236 documents that a specific covered shipment actually happened.
• DEA Form 161R — used for reexportation, when a substance previously imported into the US (or into a foreign country) needs to move on to a second country, governed by the transshipment and reexportation provisions at 21 CFR 1312.31 and 1312.32.

Filing process

Registered exporters file Form 161 either through DEA’s Import/Export online system or, less commonly now, on paper. DEA reviews the application against the registrant’s authorized activity, the substance’s schedule, and the destination country before issuing (or denying) the permit; the shipment cannot lawfully leave the US until the permit is issued. Processing and any additional documentation requirements are addressed in DEA’s published quick-reference guidance for Forms 357, 161, and 236, available through the Diversion Control Division’s import/export pages.

Frequently asked questions

What is a DEA export permit?

‘DEA export permit’ commonly refers to the permit issued after DEA approves a DEA Form 161 application — the authorization a registered exporter needs before shipping a Schedule I-V controlled substance out of the United States. The permit is transaction-specific, tied to the substance, quantity, destination, and consignee named on the application.

Can a university researcher file DEA Form 161?

Generally, no — not on a standard ‘Researcher’ DEA registration. That registration authorizes possession and use for research within the US, not export. A researcher who needs to ship a controlled research material abroad typically needs to work through an institution or partner that holds a registered-exporter registration, rather than filing Form 161 directly.

Is DEA Form 161 the same as an export license?

It functions similarly to an export license in effect — no lawful export of the covered substance can occur until DEA approves it — but it is specific to Controlled Substances Act-scheduled drugs and chemicals. It is legally distinct from an EAR or ITAR export license, which cover dual-use technology and defense articles under different statutes and agencies.

Related CASRAI entries: Export-controlled research, ITAR and EAR, OFAC List (SDN List).